Bacteraemic pneumococcal pneumonia: current therapeutic options.
about
Structure of Apo- and Monometalated Forms of NDM-1—A Highly Potent Carbapenem-Hydrolyzing Metallo-β-LactamaseZebrafish and Streptococcal InfectionsOverview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease.Factors influencing early and late mortality in adults with invasive pneumococcal disease in Calgary, Canada: a prospective surveillance studyPneumococcal colonisation density: a new marker for disease severity in HIV-infected adults with pneumonia.Risk factors for death from invasive pneumococcal disease, Europe, 2010.Fluoroquinolone efflux in Streptococcus suis is mediated by SatAB and not by SmrADiagnostic usefulness of ribosomal protein l7/l12 for pneumococcal pneumonia in a mouse model.Comparative Outcome Analysis of Penicillin-Based Versus Fluoroquinolone-Based Antibiotic Therapy for Community-Acquired Pneumonia: A Nationwide Population-Based Cohort StudyRole of pneumococcal vaccination in prevention of pneumococcal disease among adults in SingaporeAge-related immune response to pneumococcal polysaccharide vaccination: lessons for the clinic.Precision medicine for the treatment of severe pneumonia in intensive care.Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia.Efficacy of methylprednisolone in children with severe community acquired pneumonia.Blood culture fluorescence rates predict severity and mortality of invasive pneumococcal pneumonia.Understanding mortality in bacteremic pneumococcal pneumonia.
P2860
Q27674309-156A2703-A73B-4A15-A9C5-95E31210ED50Q28085714-EB0E9BD1-699C-4904-AA38-FB9889FBCB6DQ30358199-74FC280B-31CC-46D3-8611-1844287D150FQ31141633-DE90535D-4CD6-4033-81A9-B8D430A044DAQ34024693-431AFE87-F456-49B0-86F2-4BCD46CCF07DQ35130282-CD954950-CF1F-462F-9C41-7DE6F96227A7Q35598367-66C19B18-43DC-4451-85E8-5A8E89812C7DQ36506255-34A78BA0-AB56-4C52-BCE2-1D6533B78E45Q36581089-5E788922-B939-4E24-9547-C3CFE8FFE713Q37685565-201405F8-1966-4883-B18B-C7F342E0BB74Q38255618-C4F3AC6F-90D0-4761-8EBF-4E500C305EDBQ38704065-9F706E82-A725-4249-9B49-7B049A640A5EQ40102140-05AB3697-037B-4B4B-B91F-0BBF5365D354Q40286913-00FA38A2-8F74-4755-B70F-D425898EBE2AQ40986030-E9AC3866-0C3A-4104-8782-D7842B9CA66AQ44470037-16504806-06CC-49A7-AF6B-710763FFE0FC
P2860
Bacteraemic pneumococcal pneumonia: current therapeutic options.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bacteraemic pneumococcal pneumonia: current therapeutic options.
@en
Bacteraemic pneumococcal pneumonia: current therapeutic options.
@nl
type
label
Bacteraemic pneumococcal pneumonia: current therapeutic options.
@en
Bacteraemic pneumococcal pneumonia: current therapeutic options.
@nl
prefLabel
Bacteraemic pneumococcal pneumonia: current therapeutic options.
@en
Bacteraemic pneumococcal pneumonia: current therapeutic options.
@nl
P2860
P1433
P1476
Bacteraemic pneumococcal pneumonia: current therapeutic options.
@en
P2093
Charles Feldman
Ronald Anderson
P2860
P304
P356
10.2165/11585310-000000000-00000
P577
2011-01-01T00:00:00Z
P6179
1026772444